glp-1 deaths Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies FDA Warns GLP-1 Maker Over

High levels of BPA can be found

We determined the crystal structures of the UGT74F2 wild-type and T15S mutant enzymes, in different substrate/product complexes

Together, these pressures are accelerating the shift toward specialized CMOs and CDMOs with large-scale manufacturing platforms

Journal of Biomaterials Science, Polymer Edition, 21(89), 10451062

Interestingly, the inhibitor CPD-3B is virtually non-toxic to normal cells, while targeting not only GLS1 and GDH but also thioredoxin reductase (TrxR) and amidotransferase (GatCAB), resulting in the selective elimination of cancerous cells through a multifaceted mechanism